New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

First Ever Standardized, Concentrated Lignan Ingredients Will Be Launched By Acatris USA, Inc., Formerly Schouten USA Inc.

Minneapolis, MN — Acatris USA Inc., along with Acatris Holding B.V., Giessen, The Netherlands, has released the first-of-its-kind concentrated lignan extract from flax for use in dietary supplements at Supply Side East in Secaucus, NJ, May 6th-8th, 2002. Flaxseed is known as the richest source of the plant lignans—a phenolic compound with phytoestrogen activity. Acatris’ LinumLifeTM ingredients are more concentrated than any flax product or ingredient currently available on the market. The name LinumLifeTM is derived from the Latin name for flaxseed, Linum usitatissimum L.

Acatris, known for its SoyLife® and FenuLifeTM ingredients, has spent several years in researching and developing ingredients from flax primarily for their lignan content. The richest source of lignans in nature is flax; but unfortunately, most processing procedures remove significant amounts of the lignan fraction, rendering flax oil devoid of its natural phytoestrogen content (1). Through special processing, Acatris’ LinumLifeTMingredient rich in lignans is uniquely stable compared to milled flax seeds or flax oil, thereby allowing lignans to confer their phytoestrogenic activity.

Populations that consume high amounts of dietary lignans—such as vegetarians, Asians, and specific groups of people in northern Finland—appear to have a reduced risk of developing hormone-dependent cancers such as breast and prostate cancer (2). Lignans are increasingly studied for their effect on the development of benign prostatic hyperplasia (BPH). BPH is an enlargement of the prostate, which may be due to a shift in male hormone production. Enlargement of the prostate begins in most men around the age of 50 and continues for life. In fact, in Europe and North America about 50% of men over the age of 60 have enlarged prostates. Over time, this enlarging of the prostate may cause the constriction of the urethra and lead to a series of bothersome urinary tract symptoms.

Last year’s sales of flax supplements were up 53% making it one of the top supplements in the specialty non-herbal sector (3). With Acatris’ new lignan concentrate, supplement companies can take advantage of flax’s popularity in the growing men’s category of supplements.

To learn more about the latest Acatris offerings, contact Laurent Leduc, Vice President and General Manager, (USA) at P: 952-920-7700, E: [email protected]; or Liesbeth Neven, Product Manager, (Europe) at P: 31-183-44-6377, E: [email protected]

  1. Source: Flax Council of Canada
  2. Source: Adlercreutz, H and Mazur, W. Phyto-oestrogens and Western Disease. Annals of Medicine. 1997:29:95-120.
  3. Information Resources, Inc.
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.